Medical and Pediatric Oncology · 1991 · 30 citations · 15 references
MedicineOncologyPediatricsChemotherapyPediatric OncologyTumor ProgressionCancer StagingPediatric TumorsRelapsed DiseaseClinical RemissionDisease-free Survival AnalysisDisease-free Survival AssessmentIrradiation EffectsNeuroblastoma RadiotherapySecond RemissionTumor Progression After Therapy
Between January 1982 and December 1987, of 283 children with neuroblastoma treated in the Pediatric Department of Institut Gustave Roussy, 34 were stage IV-S. Two groups were distinguished according to the initial clinical presentation: 16/34 patients had life-threatening symptoms and needed immediate treatment, and 18/34 had no life-threatening symptoms. Hepatic irradiation was used in 12/16 patients of the first group with respiratory distress. Chemotherapy was used in three patients. Of these 16 patients, three patients died of progressive disease (one patient died of a reason not related to the tumor). Twelve are alive in first complete remission and one in second complete remission. Of the 18 patients of the second group, eight had spontaneous complete remission, and one of them relapsed thereafter and died despite treatment. Ten patients needed treatment, radiotherapy, and/or chemotherapy depending on the site of disease progression. Two of them died of the disease. The overall disease-free survival for these 34 patients is 75% at 90 months postdiagnosis. Using this therapeutic strategy, it was possible to avoid any treatment of metastases in 25% of the patients.
15
Do infants with stage IV-S neuroblastoma need treatment?
A. Evans, E Baum, Ronald L. Chard · Archives of Disease in Childhood · 1981 · 141 citations · Full text
Medicine, Oncology, Pediatrics +12
Congenital and Neonatal Malignant Tumors
Hart Isaacs · Journal of Pediatric Hematology/Oncology · 1987 · 108 citations
Medicine, Oncology, Pediatrics +12